125 related articles for article (PubMed ID: 11535735)
1. Dosimetry estimations for 123I-IAZA in healthy volunteers.
Stypinski D; McQuarrie SA; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
J Nucl Med; 2001 Sep; 42(9):1418-23. PubMed ID: 11535735
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.
Stypinski D; Wiebe LI; McEwan AJ; Schmidt RP; Tam YK; Mercer JR
Nucl Med Commun; 1999 Jun; 20(6):559-67. PubMed ID: 10451869
[TBL] [Abstract][Full Text] [Related]
3. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [
Stypinski D; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29470434
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Parliament MB; Chapman JD; Urtasun RC; McEwan AJ; Golberg L; Mercer JR; Mannan RH; Wiebe LI
Br J Cancer; 1992 Jan; 65(1):90-5. PubMed ID: 1310253
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
[TBL] [Abstract][Full Text] [Related]
9. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution, dosimetry and metabolism of 11beta-methoxy-(17alpha,20E/Z)-[123I]iodovinylestradiol in healthy women and breast cancer patients.
Nachar O; Rousseau JA; Lefebvre B; Ouellet R; Ali H; van Lier JE
J Nucl Med; 1999 Oct; 40(10):1728-36. PubMed ID: 10520716
[TBL] [Abstract][Full Text] [Related]
11. [131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Mercer JR; McEwan AJ; Wiebe LI
Curr Radiopharm; 2013 Jun; 6(2):87-91. PubMed ID: 23551109
[TBL] [Abstract][Full Text] [Related]
12. Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
Virgolini I; Kurtaran A; Leimer M; Smith-Jones P; Agis H; Angelberger P; Kletter K; Valent P; Linkesch W; Eichler HG
J Nucl Med; 1997 Sep; 38(9):1475-81. PubMed ID: 9293812
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
15. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Kung MP; Meegalla S; Kung HF
J Nucl Med; 1996 Jan; 37(1):151-9. PubMed ID: 8543985
[TBL] [Abstract][Full Text] [Related]
18. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Newberg AB; Wintering NA; Plössl K; Hochold J; Stabin MG; Watson M; Skovronsky D; Clark CM; Kung MP; Kung HF
J Nucl Med; 2006 May; 47(5):748-54. PubMed ID: 16644743
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
20. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
